3 assets in Cisplatin Toxicity

Therapeutic assets addressing Cisplatin Toxicity, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cis-Diamminedichloroplatinum Ii Cisplatin Toxicity	Peking University First Hospital	P2	CCC (53)
Dapagliflozin Cisplatin Toxicity	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	P2	CCC (53)
Vinorelbine Ditartrate Cisplatin Toxicity	Peking University First Hospital	P2	CCC (53)